🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsOral GLP-1 pipeline overview — all agents in development Page 4

Oral GLP-1 pipeline overview — all agents in development

TrialTracker_MD Mon, Feb 26, 2024 at 4:00 PM 291 replies 50,237 viewsPage 4 of 20
kevin_tulsa
Member
489
2,123
Jun 2024
Tulsa, OK
Feb 28, 2024 at 4:21 PM#16
hyun_seoul said:
It helps to say which part of this you are uncertain about.

Same pattern here, and in the same order. I had assumed I was the exception until I read this.

12 10fiona_glasgow, Dr.RheumBOS, greg_boulder and 9 others
Reply Quote Save Share Report
PharmD_Rodriguez
Senior Member
3,456
14,567
Jan 2024
Miami, FL
Feb 28, 2024 at 11:11 PM#17

From the other side of the consultation, briefly. Take it one variable at a time. Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent argument can untangle them after the fact.

13 11TinaHashiRN, robert_kc, dan_philly and 10 others
Reply Quote Save Share Report
marco_milano
Member
345
1,456
Jul 2024
Milan, IT
Feb 29, 2024 at 6:01 AM#18
PharmD_Rodriguez said:
Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent…

Same experience, arrived at from the opposite direction.

14 12Dr.LipidDallas, alex_tucson, kevin_tulsa and 11 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
cory_ATX
Member
456
2,123
Jul 2024
Austin, TX
Feb 29, 2024 at 12:51 PM#19
PharmD_Rodriguez said:
Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent…

Adding the part of the answer the thread has not reached. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

Last edited: Feb 29, 2024 at 2:51 PM
15 13Dr.PathRoch, mona_PHX, andrew_nyc and 12 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Feb 29, 2024 at 7:41 PM#20

Moderator note: leaving this open. It is being argued well and the disagreement is the useful part. Thread quality here is what the rules are for. Keep it up.

37 10PurityPaulOR, MaxMetOK, MounjBrad and 34 others
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register